Home
|Insights
|"U.S. Healthcare Reform: What's in it for Biosimilars?" European Generics Medicines Association's 8th Annual Symposium on Biosimilars, London

PDF Link

"U.S. Healthcare Reform: What's in it for Biosimilars?" European Generics Medicines Association's 8th Annual Symposium on Biosimilars, London

Speaking Engagement | 09.09.10

Contacts

Keith J. Harrison
Partner
He/Him/His
- Washington, D.C.
  - D | +1.202.624.2560
a2hhcnJpc29uQGNyb3dlbGwuY29t

Insights

Speaking Engagement | 12.05.25

"Key Takeaways From DOJ's Civil Cyber-Fraud Initiative," ABA Cyber Meeting

Speaking Engagement | 12.04.25
ACI 30th Annual Conference on Drug & Medical Device Litigation
Speaking Engagement | 12.04.25
"Cross-Functional Collaboration: Strategies for Clear Communication and Training Across Functions and Jurisdictions," ACI's 15th Annual New York Forum on Economic Sanctions
Speaking Engagement | 12.04.25
"The Rise of Outbound Investment Rules and the Intersection with Sanctions and Export Controls: New Legal and Compliance Considerations Affecting Transactions," ACI's 15th Annual New York Forum on Economic Sanctions

View All Insights

Subscribe

to the latest insights from our team